跳至主要内容
临床试验/EUCTR2019-001478-27-IT
EUCTR2019-001478-27-IT进行中(未招募)1 期

Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in gastric carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcomes. A collaborative randomized controlled trial of: ACOI, FONDAZIONE AIOM, SIC, SICE, SICO. GOETH STUDY - GOETH STUDY

Associazione Chirurghi Ospedalieri Italiani0 个研究点目标入组 240 人开始时间: 2021年6月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients with histologically documented gastric carcinoma (diffuse/intestinal histotype) eligibile for R0:
  • a)Presurgical or intraoperative stage T3-T4 N0-N+ primary tumour (TNM 8 th).
  • b)Urgent presentation: perforation without purulent generalized peritonitis
  • c)Positive cytology of peritoneal fluid (if previously obtained)
  • 2.Age = 18 years and =75 years.
  • 3.Written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 120

排除标准

  • 1.Gastroesophageal Junction (GEJ) cancer
  • 2.Distant metastatic disease (even if limited and completely resected)
  • 3.Peritoneal carcinomatosis
  • 4.History of tumour diagnosed in the 3 years before entering the study, except for topical and healed pathologies that do not need further treatment (e.g. non-melanoma skin carcinomas, superficial bladder carcinomas or in situ carcinoma of the breast or cervix).
  • 5.Psychological, family or social conditions which may negatively affect the treatment and follow-up protocol.
  • 6.Poor general conditions (ECOG > 2).
  • 7.Impaired cardiac function (history of congestive heart failure or FE <40%). Clinically significant cardiovascular disease: cerebral vascular accident/stroke (< 6 months prior to enrolment), unstable angina, congestive heart failure (New York Heart Association Classification Class > II) or serious uncontrolled cardiac Arrhythmia requiring medication
  • 8.Impaired renal function (creatinine> 1.5 upper limit of normal or creatinine clearance <60 mL / min).
  • 9.Impaired hepatic function (AST, ALT >2.5 upper limit of normal, bilirubin > 1.5 upper limit of normal).
  • 10.Impaired hematopoietic function (leucocytes <4000 / mm3, neutrophils <1500 / mm 3, platelets <100000 / mm3).
  • 11.Impaired pulmonary function (presence of COPD or other pulmonary restrictive conditions with FEV1 <50% or DLCO <40% of normal age value).
  • 12.History or presence of other disease, metabolic dysfunction, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates use of HIPEC or chemotherapy or patient at high risk from treatment complications.
  • 13.Pregnancy.
  • 14.Krukenberg tumor
  • 15.Refusal to join the study.

研究者

相似试验

进行中(未招募)
1 期
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosispatients with colorectal carcinoma at high risk peritoneal carcinomatosisMedDRA version: 21.1Level: PTClassification code 10061045Term: Colon neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-001437-14-ITAssociazione Chirurghi Ospedalieri Italiani330
进行中(未招募)
不适用
Surgery plus intraperitoneal hyperthermic chemoterapy in platinum-resistant patients with ovarian cancer reccurrence. A Phase II study.
EUCTR2005-000929-31-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中(未招募)
不适用
Surgery plus intraperitoneal Hypertermic chemotherapy in platinum-sensitive patients with ovarian cancer recurrence after 12 months. Phase II studyRecurrent ovarian cancerMedDRA version: 6.1Level: PTClassification code 10033128
EUCTR2005-000927-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
已完成
Unknown
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and JapaColorectal Cancer with Peritoneal Metastases
JPRN-UMIN000051539Yonsei University College of Medicine166
进行中(未招募)
1 期
Feasibility of a chemotherapy with the two agents Carboplatin and Paclitaxel, that is applied heated directly into the abdomen after surgery of patients with advanced cancer of the ovaryOtherwise treatment-naive patients with epithelial ovarian cancer, FIGO III - IVa
EUCTR2012-003244-76-ATMedical University of Vienna20